BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lancelot M, Miller MJ, Roback J, Stowell SR. Refractory thrombotic thrombocytopenic purpura related to checkpoint inhibitor immunotherapy. Transfusion 2021;61:322-8. [PMID: 33119913 DOI: 10.1111/trf.16117] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Onwuemene OA, Nnoruka CI, Patriquin CJ, Connelly-Smith LS. Therapeutic plasma exchange in the management of immune checkpoint inhibitor-associated immune-related adverse effects: A review. Transfusion 2022. [PMID: 36134464 DOI: 10.1111/trf.17114] [Reference Citation Analysis]
2 Moore DC, Elmes JB, Arnall JR, Strassels SA, Patel JN. Acquired thrombotic thrombocytopenic purpura associated with immune checkpoint inhibitors: A real-world study of the FDA adverse event reporting system. Int Immunopharmacol 2022;110:109015. [PMID: 35803131 DOI: 10.1016/j.intimp.2022.109015] [Reference Citation Analysis]
3 Buetler VA, Agbariah N, Schild DP, Liechti FD, Wieland A, Andina N, Hammann F, Kremer Hovinga JA. Immune-Mediated Thrombotic Thrombocytopenic Purpura Following mRNA-Based COVID-19 Vaccine BNT162b2: Case Report and Mini-Review of the Literature. Front Med (Lausanne) 2022;9:890661. [PMID: 35655852 DOI: 10.3389/fmed.2022.890661] [Reference Citation Analysis]
4 Font C, de Herreros MG, Tsoukalas N, Brito-Dellan N, Espósito F, Escalante C, Oo TH; MASCC Hemostasis Study Group. Thrombotic microangiopathy (TMA) in adult patients with solid tumors: a challenging complication in the era of emerging anticancer therapies. Support Care Cancer 2022. [PMID: 35545722 DOI: 10.1007/s00520-022-06935-5] [Reference Citation Analysis]
5 Gilbar PJ, Dickey MS. Case reports of acquired thrombotic thrombocytopenic purpura attributed to pembrolizumab. J Oncol Pharm Pract. [DOI: 10.1177/10781552221088025] [Reference Citation Analysis]
6 Colonne CK, Favaloro EJ, Pasalic L. The Intriguing Connections between von Willebrand Factor, ADAMTS13 and Cancer. Healthcare 2022;10:557. [DOI: 10.3390/healthcare10030557] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Pasquale R, Giannotta JA, Barcellini W, Fattizzo B. Bortezomib in autoimmune hemolytic anemia and beyond. Ther Adv Hematol 2021;12:20406207211046428. [PMID: 34795889 DOI: 10.1177/20406207211046428] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
8 De Filippis S, Moore C, Ezell K, Aggarwal K, Kelkar AH. Immune Checkpoint Inhibitor-Associated Thrombotic Thrombocytopenic Purpura in a Patient With Metastatic Non-Small-Cell Lung Cancer. Cureus 2021;13:e16035. [PMID: 34345535 DOI: 10.7759/cureus.16035] [Cited by in F6Publishing: 1] [Reference Citation Analysis]